Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs Grace Therapeutics, Inc. (GRCE)

Elicio Therapeutics, Inc. and Grace Therapeutics, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Grace Therapeutics, Inc. are of similar size ($37.9M and $37.5M). Grace Therapeutics, Inc. grew revenue faster over the last twelve months: 1,286.8% against 921.0%. Across the 13 metrics below, Grace Therapeutics, Inc. leads on 9 and Elicio Therapeutics, Inc. on 4.

Valuation

Metric ELTX GRCE Biotechnology median
P/E n/m n/m 10.60
P/S 1.01 160.85 9.40
P/B 3.69 0.67 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.56 106.08 9.02
Earnings yield (142.76%) (63.44%) (32.88%)
Free cash flow yield (129.21%) (31.78%) (23.13%)

Profitability

Metric ELTX GRCE Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (36.19%) (51.96%)
Return on assets (124.36%) (33.74%) (46.06%)
Return on invested capital 0.00% (43.36%) 0.00%

Growth

Metric ELTX GRCE Biotechnology median
Revenue growth (TTM) 921.02% 1,286.81% 6.76%
EPS growth (last fiscal year) 39.29% 40.51% 29.88%
Revenue growth, 5-year CAGR — (22.91%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX GRCE Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 11.47 4.97
Net debt to EBITDA 0.25 1.53 1.01

Dividend

Metric ELTX GRCE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELTX GRCE Biotechnology median
Market cap 37.93m 37.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack